Key points are not available for this paper at this time.
Patients with PsA included in real-world studies had similar prevalence of MDA compared to those in controlled clinical trials. This finding suggests that MDA is a useful treatment target for PsA in the real-world setting.
Zardin-Moraes et al. (2019) studied this question.